Shenzhen Kangtai Biological Products Co (SZSE:300601) Accounts Payable & Accrued Expense : ¥2,373 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Kangtai Biological Products Co Accounts Payable & Accrued Expense?

Shenzhen Kangtai Biological Products Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥2,315 Mil) to Dec. 2023 (¥2,629 Mil) but then declined from Dec. 2023 (¥2,629 Mil) to Mar. 2024 (¥2,373 Mil).

Shenzhen Kangtai Biological Products Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥1,721 Mil) to Dec. 2022 (¥2,034 Mil) and increased from Dec. 2022 (¥2,034 Mil) to Dec. 2023 (¥2,629 Mil).

Shenzhen Kangtai Biological Products Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shenzhen Kangtai Biological Products Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Kangtai Biological Products Co Accounts Payable & Accrued Expense Chart

Shenzhen Kangtai Biological Products Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

775.24

1,717.57

1,720.67

2,033.97

2,629.35

Shenzhen Kangtai Biological Products Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,899.80	2,078.45	2,315.02	2,629.35	2,372.53

Shenzhen Kangtai Biological Products Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shenzhen Kangtai Biological Products Co (SZSE:300601) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Kangtai Biological Products Co Ltd (SZSE:300601) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 6 Kefa Road, Science and Technology Industrial Park, Nanshan District, Shenzhen, CHN, 518057

Website

http://www.biokangtai.com

Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.

Executives

Liu Jian Kai	Directors, executives
Tao Jin	Secretary Dong
Zheng Hai Fa	Directors, executives
Zhou Hui	Executives
Miao Xiang	Directors, executives
Wen Fei Dong	Director
Du Wei Min	Directors, executives
Lv Zhi Yun	Supervisors
Gan Jian Hui	Executives
Zhu Zheng Yu	Executives
Liu Qun	Executives
Li Tong	Executives
Yuan Li Ping	Director
Li Xiang Ming	Independent director

Shenzhen Kangtai Biological Products Co (SZSE:300601) Headlines

No Headlines